Personal information

Other IDs

Scopus Author ID: 56862344100

Countries

France

Activities

Collapse all

Employment (4)

Evotec France SAS: Toulouse, Languedoc-Roussillon-Midi, FR

2022-01-10 to present | Research scientist (Synthetic chemistry )
Employment
Source: Self-asserted source
Sebastien Benizri

Centre Européen de Recherche et d'Enseignement des Géosciences de l'Environnement: Aix en Provence, Provence-Alpes-Côte d'Azur, FR

2019-12-31 to 2022-01-09 | Post Doc
Employment
Source: Self-asserted source
Sebastien Benizri

INSERM U1212: Bordeaux, Aquitaine, FR

2018-07-12 to 2019-12-30 | Post Doc
Employment
Source: Self-asserted source
Sebastien Benizri

Inserm U1212: Bordeaux, Aquitaine, FR

2015-04-01 to 2018-07-11 | Ph.D. Student
Employment
Source: Self-asserted source
Sebastien Benizri

Works (14)

FXYD2 antisense oligonucleotide provides an efficient approach for long-lasting relief of chronic peripheral pain

JCI Insight
2023-05-08 | Journal article
DOI: 10.1172/jci.insight.161246
Contributors: Alexandre Derre; Noelian Soler; Valentine Billoux; Sebastien Benizri; Brune Vialet; Cyril Rivat; Philippe Barthélémy; Patrick Carroll; Alexandre Pattyn; Stephanie Venteo
Source: check_circle
Crossref

Electropolymerizable Thiophene–Oligonucleotides for Electrode Functionalization

ACS Applied Materials & Interfaces
2022-06-15 | Journal article
DOI: 10.1021/acsami.2c02993
Contributors: Getnet S. Kassahun; Eliana D. Farias; Sebastien Benizri; Claudio Mortier; Alexandra Gaubert; Gerardo Salinas; Patrick Garrigue; Alexander Kuhn; Dodzi Zigah; Philippe Barthélémy
Source: check_circle
Crossref

Hydrogel based lipid-oligonucleotides: a new route to self-delivery of therapeutic sequences

Biomaterials Science
2021 | Journal article
DOI: 10.1039/D1BM00273B
Contributors: Sébastien Benizri; Alexandra Gaubert; Charlotte Soulard; Étienne Gontier; Isabelle Svahn; Palma Rocchi; Gaëlle Vacher; Philippe Barthélémy
Source: check_circle
Crossref

Bolaamphiphile-based supramolecular gels with drugs eliciting membrane effects

Journal of Colloid and Interface Science
2021-07 | Journal article
DOI: 10.1016/j.jcis.2021.03.026
Contributors: Laurent Latxague; Sébastien Benizri; Alexandra Gaubert; James Tolchard; Denis Martinez; Estelle Morvan; Axelle Grélard; Ahmad Saad; Birgit Habenstein; Antoine Loquet et al.
Source: check_circle
Crossref

Antisense Oligonucleotide-Based Therapeutic against Menin for Triple-Negative Breast Cancer Treatment

Biomedicines
2021-07-08 | Journal article
DOI: 10.3390/biomedicines9070795
Contributors: Dang Tan Nguyen; Thi Khanh Le; Clément Paris; Chaïma Cherif; Stéphane Audebert; Sandra Oluchi Udu-Ituma; Sébastien Benizri; Philippe Barthélémy; François Bertucci; David Taïeb et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Nucleoside-Lipid-Based Nanoparticles for Phenazine Delivery: A New Therapeutic Strategy to Disrupt Hsp27-eIF4E Interaction in Castration Resistant Prostate Cancer

Pharmaceutics
2021-04-27 | Journal article
DOI: 10.3390/pharmaceutics13050623
Contributors: Hajer Ziouziou; Clément Paris; Sébastien Benizri; Thi Khanh Le; Claudia Andrieu; Dang Tan Nguyen; Ananda Appavoo; David Taïeb; Frédéric Brunel; Ridha Oueslati et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Analysis of lipid-oligonucleotide conjugates by cyclodextrin-modified capillary zone electrophoresis

Talanta
2020-05-20 | Journal article
DOI: 10.1016/j.talanta.2020.121204
Part of ISSN: 0039-9140
Source: Self-asserted source
Sebastien Benizri
grade
Preferred source (of 2)‎

Lipid oligonucleotides as a new strategy for tackling the antibiotic resistance

Scientific Reports
2020-01-23 | Journal article
DOI: 10.1038/s41598-020-58047-x
Part of ISSN: 2045-2322
Source: Self-asserted source
Sebastien Benizri
grade
Preferred source (of 2)‎

DDX5, une nouvelle cible thérapeutique dans le cancer de prostate résistant à la castration

Progrès en Urologie
2019-11 | Journal article
DOI: 10.1016/j.purol.2019.08.142
Part of ISSN: 1166-7087
Source: Self-asserted source
Sebastien Benizri

Bioconjugated Oligonucleotides: Recent Developments and Therapeutic Applications

Bioconjugate Chemistry
2019-02-20 | Journal article
DOI: 10.1021/acs.bioconjchem.8b00761
Part of ISSN: 1043-1802
Part of ISSN: 1520-4812
Source: Self-asserted source
Sebastien Benizri
grade
Preferred source (of 2)‎

Nucleoside-Lipid-Based Nanocarriers for Sorafenib Delivery

Nanoscale Research Letters
2018-01 | Journal article
DOI: 10.1186/s11671-017-2420-2
Part of ISSN: 1931-7573
Part of ISSN: 1556-276X
Source: Self-asserted source
Sebastien Benizri
grade
Preferred source (of 2)‎

Lipid-oligonucleotide conjugates improve cellular uptake and efficiency of TCTP-antisense in castration-resistant prostate cancer

Journal of Controlled Release
2017-07 | Journal article
DOI: 10.1016/j.jconrel.2017.04.042
Part of ISSN: 0168-3659
Source: Self-asserted source
Sebastien Benizri
grade
Preferred source (of 2)‎

Uracile based glycosyl-nucleoside-lipids as low molecular weight organogelators

New Journal of Chemistry
2016 | Journal article
DOI: 10.1039/c6nj02675c
Part of ISSN: 1144-0546
Part of ISSN: 1369-9261
Source: Self-asserted source
Sebastien Benizri
grade
Preferred source (of 2)‎

pH-Cleavable Nucleoside Lipids: A New Paradigm for Controlling the Stability of Lipid-Based Delivery Systems

ChemMedChem
2015-11 | Journal article
DOI: 10.1002/cmdc.201500381
Part of ISSN: 1860-7179
Source: Self-asserted source
Sebastien Benizri
grade
Preferred source (of 2)‎
How many people are using ORCID?